Corrigendum: An immunogenic personal neoantigen vaccine for patients with melanoma
- PMID: 29542692
- PMCID: PMC6064631
- DOI: 10.1038/nature25145
Corrigendum: An immunogenic personal neoantigen vaccine for patients with melanoma
Abstract
This corrects the article DOI: 10.1038/nature22991.
Erratum for
-
An immunogenic personal neoantigen vaccine for patients with melanoma.Nature. 2017 Jul 13;547(7662):217-221. doi: 10.1038/nature22991. Epub 2017 Jul 5. Nature. 2017. PMID: 28678778 Free PMC article. Clinical Trial.
Similar articles
-
Corrigendum to "Calcium Channel Expression and Applicability as Targeted Therapies in Melanoma".Biomed Res Int. 2016;2016:3017536. doi: 10.1155/2016/3017536. Epub 2016 Aug 17. Biomed Res Int. 2016. PMID: 27610370 Free PMC article.
-
Corrigendum: Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma.Sci Rep. 2017 May 26;7:46833. doi: 10.1038/srep46833. Sci Rep. 2017. PMID: 28548101 Free PMC article.
-
Corrigendum: An ethnically relevant consensus Korean reference genome is a step towards personal reference genomes.Nat Commun. 2017 Oct 9;8:16168. doi: 10.1038/ncomms16168. Nat Commun. 2017. PMID: 28991236 Free PMC article.
-
Corrigendum to "Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo".Evid Based Complement Alternat Med. 2015;2015:760692. doi: 10.1155/2015/760692. Epub 2015 Nov 18. Evid Based Complement Alternat Med. 2015. PMID: 26664455 Free PMC article.
-
Vaccines and melanoma.Hematol Oncol Clin North Am. 2014 Jun;28(3):559-69. doi: 10.1016/j.hoc.2014.02.008. Epub 2014 Apr 3. Hematol Oncol Clin North Am. 2014. PMID: 24880947 Review.
Cited by
-
Comprehensive Analyses Identify APOBEC3A as a Genomic Instability-Associated Immune Prognostic Biomarker in Ovarian Cancer.Front Immunol. 2021 Oct 21;12:749369. doi: 10.3389/fimmu.2021.749369. eCollection 2021. Front Immunol. 2021. PMID: 34745121 Free PMC article.
-
Revamping Hepatocellular Carcinoma Immunotherapy: The Advent of Microbial Neoantigen Vaccines.Vaccines (Basel). 2024 Aug 21;12(8):930. doi: 10.3390/vaccines12080930. Vaccines (Basel). 2024. PMID: 39204053 Free PMC article. Review.
-
Cancer research in the era of immunogenomics.ESMO Open. 2018 Dec 26;3(7):e000475. doi: 10.1136/esmoopen-2018-000475. eCollection 2018. ESMO Open. 2018. PMID: 30622743 Free PMC article. Review.
-
Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response.Signal Transduct Target Ther. 2022 Sep 19;7(1):331. doi: 10.1038/s41392-022-01136-2. Signal Transduct Target Ther. 2022. PMID: 36123348 Free PMC article. Review.
-
Tumor neoantigen heterogeneity impacts bystander immune inhibition of pancreatic cancer growth.Transl Oncol. 2020 Dec;13(12):100856. doi: 10.1016/j.tranon.2020.100856. Epub 2020 Aug 28. Transl Oncol. 2020. PMID: 32862105 Free PMC article.
References
-
- Nature. 2017 Jul 13;547(7662):217-221 - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources